Hemophilia Stocks List

Hemophilia Stocks Recent News

Date Stock Title
May 31 PFE Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug
May 31 BIIB Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
May 31 PFE The Most Profitable Biotechnology Company in the World
May 31 PFE Moderna Looks for Boost From Newly Approved RSV Shot
May 31 PFE Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
May 31 BIIB Repligen (RGEN) Down 10.9% Since Last Earnings Report: Can It Rebound?
May 31 PFE Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
May 31 BIIB Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
May 31 PFE Pfizer posts long-term data to support lung cancer therapy Lorbrena
May 31 PFE Pfizer gene therapy for haemophilia B therapy endorsed in EU
May 31 BIIB How To Invest: Using Shorter-Term Moving Averages To Trade Stocks
May 31 PFE Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
May 31 PFE Moderna wins FDA approval for RSV vaccine
May 31 PFE Ginkgo Bioworks Stock: Bull vs. Bear
May 31 BIIB European Commission approves Biogen’s QALSODY for ALS treatment
May 31 PFE Is Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?
May 30 BIIB EU approves Biogen treatment for genetic form of ALS
May 30 BIIB Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
May 30 SGMO Russell 3000: Inovio, Ocugen among healthcare additions; Assertio, Ginkgo Bioworks among deletions
May 30 BAX Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29
Hemophilia

Haemophilia is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding. This results in people bleeding longer after an injury, easy bruising, and an increased risk of bleeding inside joints or the brain. Those with a mild case of the disease may have symptoms only after an accident or during surgery. Bleeding into a joint can result in permanent damage while bleeding in the brain can result in long term headaches, seizures, or a decreased level of consciousness.There are two main types of haemophilia: haemophilia A, which occurs due to not enough clotting factor VIII, and haemophilia B, which occurs due to not enough clotting factor IX. They are typically inherited from one's parents through an X chromosome with a nonfunctional gene. Rarely a new mutation may occur during early development or haemophilia may develop later in life due to antibodies forming against a clotting factor. Other types include haemophilia C, which occurs due to not enough factor XI, and parahaemophilia, which occurs due to not enough factor V. Acquired haemophilia is associated with cancers, autoimmune disorders, and pregnancy. Diagnosis is by testing the blood for its ability to clot and its levels of clotting factors.Prevention may occur by removing an egg, fertilizing it, and testing the embryo before transferring it to the uterus. Treatment is by replacing the missing blood clotting factors. This may be done on a regular basis or during bleeding episodes. Replacement may take place at home or in hospital. The clotting factors are made either from human blood or by recombinant methods. Up to 20% of people develop antibodies to the clotting factors which makes treatment more difficult. The medication desmopressin may be used in those with mild haemophilia A. Studies of gene therapy are in early human trials.Haemophilia A affects about 1 in 5,000–10,000, while haemophilia B affects about 1 in 40,000, males at birth. As haemophilia A and B are both X-linked recessive disorders, females are rarely severely affected. Some females with a nonfunctional gene on one of the X chromosomes may be mildly symptomatic. Haemophilia C occurs equally in both sexes and is mostly found in Ashkenazi Jews. In the 1800s haemophilia was common within the royal families of Europe. The difference between haemophilia A and B was determined in 1952. The word is from the Greek haima αἷμα meaning blood and philia φιλία meaning love.

Browse All Tags